コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 se manifested as a spectrum of predominantly infantile-onset (14/18, 78%) and variably progressive ne
3 with onset in infancy (ENDI) syndromes, but infantile-onset agammaglobulinemia with no mature B cell
4 -onset disease is typically more severe than infantile-onset and adult-onset disease, long-term morbi
5 iaphragm muscle is severely affected in both infantile-onset and late-onset individuals, with death o
7 n early-onset amyotrophic lateral sclerosis, infantile-onset ascending hereditary spastic paraplegia
9 ion (IVS18+2t-->a) in a patient with classic infantile-onset autosomal recessive glycogen storage dis
12 vity is a potential targetable mechanism for infantile-onset cardiomyopathy, a common manifestation o
14 emonstrate that FHF2 variants are a cause of infantile-onset developmental and epileptic encephalopat
15 e drug-resistant seizures and, in cases with infantile onset, developmental regression can follow.
16 rgeted 266 CAG repeats (a number that causes infantile-onset disease) into the mouse Sca7 locus to ge
17 sociated with distinct recessive or x-linked infantile onset disorders, resulting from defects in mit
21 yelination with spastic quadriplegia, and an infantile onset encephalopathy, suggesting multiple cell
25 phenotype with mild cognitive impairment and infantile onset epilepsy (focal seizures, fever sensitiv
26 eptic encephalopathy, characterized by early-infantile onset epilepsy and hypotonia with additional v
27 ied a small family with autosomal recessive, infantile onset epilepsy and intellectual disability.
28 cted individuals presented DEE with neonatal/infantile-onset epilepsy (n = 6/6), global developmental
29 e we describe two unrelated individuals with infantile-onset epilepsy and abnormalities of brain morp
30 se Dravet syndrome (DS), a pharmacoresistant infantile-onset epilepsy syndrome with comorbidities of
31 his gene has been previously associated with infantile-onset epilepsy syndromes in two other cohorts.
32 l loss of function, and with the neonatal or infantile onset epileptic encephalopathies due to KCNQ2
34 ere myoclonic epilepsy in infancy (SMEI), an infantile-onset epileptic encephalopathy characterized b
38 ing developmental delay, seizures (primarily infantile onset focal epilepsy), microcephaly and a reco
44 or mouse models may correspond to the severe infantile onset forms of NPC disease, Npc1(nmf164) mice
45 C3-were associated with both adult-onset and infantile-onset forms of disease, which also differed in
46 Dravet syndrome is an epilepsy syndrome of infantile onset, frequently caused by SCN1A mutations or
48 eyes of 5 patients (4 Type I, 1 Type II) had infantile-onset glaucoma, and all eyes required glaucoma
49 splantation (HSCT) is the only treatment for infantile-onset GLD; however, clinical outcomes of HSCT
52 lopmental syndrome characterized by profound infantile-onset hypotonia and developmental delay throug
54 nt stem cells (iPSCs) were generated from an infantile-onset IBD patient lacking a functional IL10RB
55 presented before the age of one with severe infantile-onset IBD, failure to thrive, skin rash, and p
56 isease is hypothesised to be between that of infantile-onset (ie, <6 years old) and adult-onset disea
57 odies against interleukin-10 in a child with infantile-onset inflammatory bowel disease (IBD), a phen
61 ndrially encoded MTATP6 gene typically cause infantile-onset Leigh syndrome and, occasionally, have o
62 diseases with severity ranging from lethal, infantile-onset (Leigh syndrome spectrum) to milder with
63 occur almost as often as those with an early infantile onset (<3 months), and are thus more frequent
64 neuron (SMN) protein triggers the oft-fatal infantile-onset motor neuron disorder, spinal muscular a
66 biallelic mutation in the PTRH2 gene causes infantile-onset multisystem disease with progressive mus
69 ng in a novel phenotype that includes severe infantile onset myoclonus, hypotonia, optic nerve abnorm
72 t siblings of consanguineous parents with an infantile-onset neurodegenerative disorder manifesting a
73 patients presented with a complex, neonatal/infantile onset neurological and neurodevelopmental synd
81 d from familial hemiplegic migraine (FHM) by infantile onset of the characteristic symptoms and high
83 ype than deletion of either gene alone, with infantile onset pan-enteric polyposis and a high mortali
84 ients in the cohort presented with classical infantile-onset parkinsonism dystonia, with one survivin
90 SLC12A5 mutations in patients with a severe infantile-onset pharmacoresistant epilepsy syndrome, epi
92 ple of Southern Han Chinese ancestry, causes infantile-onset Pompe disease (IOPD), presenting neonata
94 reprogrammed fibroblasts from patients with infantile-onset Pompe disease to generate induced plurip
98 larly undefined form of NCL characterized by infantile-onset progressive myoclonic epilepsy (PME), vi
100 cted in dopamine transporter mutants causing infantile-onset rather than juvenile-onset disease.
101 dividuals with severe, sporadic disorders of infantile onset represent an important class of disease
102 Clinical features demonstrated a severe infantile onset retinal dystrophy, similar to Leber cong
105 terized clinically by acquired microcephaly, infantile-onset seizures, psychomotor retardation, chore
106 uNAc; sialic acid), in nine individuals with infantile-onset severe developmental delay and skeletal
107 ved in the O-mannosylation pathway result in infantile-onset, severe developmental defects involving
108 ulminant neonatal worsening of patients with infantile onset SMA and identify a temporal window for m
111 -onset pure hereditary spastic paraplegia to infantile-onset spastic tetraplegia associated with glob
112 -onset pure hereditary spastic paraplegia to infantile-onset spasticity and global developmental dela
119 underlying autosomally recessively inherited infantile onset spinocerebellar ataxia (IOSCA), we ident
126 gly, the miRNA profile in the acute stage of infantile-onset TLE overlaps in dysregulation of miR-132
128 deficiency produces two phenotypes, a severe infantile-onset variant, Wolman disease (WD), and a late
129 (MLC) is a genetic disease characterized by infantile onset white matter edema and delayed onset neu
130 rodegeneration as well as corneal opacity of infantile-onset with epithelial autofluorescent lysosoma